|
|
Volumn 19, Issue 4, 2003, Pages 325-326
|
|
More answers and more questions in inflammatory bowel disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
AZATHIOPRINE;
CYTOKINE;
IMMUNOSUPPRESSIVE AGENT;
MERCAPTOPURINE;
PROBIOTIC AGENT;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
ANTIBIOTIC THERAPY;
ANTIGEN RECOGNITION;
CARCINOGENESIS;
CHRONIC INFLAMMATION;
CLINICAL FEATURE;
CROHN DISEASE;
CYTOKINE PRODUCTION;
DIAGNOSTIC PROCEDURE;
DISEASE ASSOCIATION;
DISEASE CLASSIFICATION;
DISEASE MODEL;
DYSPLASIA;
EDITORIAL;
ENTERITIS;
GENETIC ASSOCIATION;
GENETIC SUSCEPTIBILITY;
IMMUNE SYSTEM;
IMMUNOCOMPETENT CELL;
IMMUNOMODULATION;
IMMUNOSUPPRESSIVE TREATMENT;
INFLAMMATION;
INTESTINE FLORA;
INTESTINE MUCOSA;
MUCOSAL IMMUNITY;
NONHUMAN;
PATHOGENESIS;
RISK FACTOR;
SCLEROSING CHOLANGITIS;
T LYMPHOCYTE;
TH1 CELL;
TH2 CELL;
TISSUE INJURY;
ULCERATIVE COLITIS;
|
|
EID: 0037662121
PISSN: 02671379
EISSN: None
Source Type: Journal
DOI: 10.1097/00001574-200307000-00001 Document Type: Editorial |
|
Times cited : (6)
|
|
References (0)
|
